Weekly Paclitaxel as Third-line Chemotherapy in Patients With Metastatic Transitional Cell Carcinoma of Urothelial Tract: Results of a Phase II Study

被引：0
|
作者：
Rozzi, A. [1 ]
Nardoni, C. [1 ]
Corona, M. [1 ]
Falbo, T. [2 ]
De Marco, F. [3 ]
Grillenzoni, L. [3 ]
Lanzetta, G. [4 ]
机构：
[1] Ist Neurotraumatol, Clin Oncol Unit, I-00185 Grottaferrata, Italy
[2] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy
[3] Ist Neurotraumatol Italiano INI Grottaferrata, Div Urol, Rome, Italy
[4] Ist Neurotraumatol Italiano INI Grottaferrata, Clin Oncol Unit, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72059-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [41] WEEKLY PACLITAXEL, CARBOPLATIN AND TRASTUZUMAB (WPCH) AS SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH HER2+METASTATIC BREAST CANCER: RESULTS OF A PHASE II STUDY
    Rozzi, Antonio
    Nardoni, Chiara
    Corona, Michela
    Restuccia, Maria Rosa
    Lanzetta, Gaetano
    ANNALS OF ONCOLOGY, 2009, 20
  • [42] WEEKLY REGIMEN OF PACLITAXEL-CARBOPLATIN-CETUXIMAB AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SSCHN): RESULTS OF A PHASE II STUDY
    Rozzi, A.
    Lenci, G.
    Corona, M.
    Nardoni, C.
    Restuccia, M. R.
    Falbo, T.
    Nappa, M.
    Costa, A. M.
    Spigone, B.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 323 - 323
  • [43] Phase II trial of pazopanib and weekly paclitaxel in metastatic urothelial cancer (UC).
    Srinivas, Sandy
    Narayanan, Sujata
    Harshman, Lauren Christine
    Lam, Anthony P.
    Vaishampayan, Ulka N.
    Haas, Denise
    Poushnejad, Shermeen
    Pachynski, Russell
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [44] Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer
    Tajima, Hidehiro
    Okazaki, Mitsuyoshi
    Yamaguchi, Takahisa
    Ohbatake, Yoshinao
    Okamoto, Koichi
    Nakanuma, Shinichi
    Terai, Shiro
    Sakai, Seisho
    Kinoshita, Jun
    Makino, Isamu
    Nakamura, Keishi
    Hayashi, Hironori
    Oyama, Katsunobu
    Inokuchi, Masafumi
    Miyashita, Tomoharu
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Fushida, Sachio
    Ohta, Tetsuo
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (04) : 623 - 627
  • [45] Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
    Hitt, R.
    Irigoyen, A.
    Cortes-Funes, H.
    Grau, J. J.
    Garcia-Saenz, J. A.
    Cruz-Hernandez, J. J.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 1016 - 1022
  • [46] Pazopanib versus paclitaxel in relapsed urothelial tumors: A randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive transitional cell carcinoma of the urothelium (PLUTO).
    Jones, Robert J.
    Chester, John D.
    Dixon-Hughes, Judith
    Alexander, Laura
    Bahl, Amit
    Hussain, Syed A.
    Birtie, Alison
    Jagdev, Satinder
    Morris, Anna
    Stobo, Jamie
    Bray, Caroline A.
    Paul, James
    Powies, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] A phase II study of DaunoXome® in advanced urothelial transitional cell carcinoma
    Fosså, SD
    Aass, N
    Parö, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (07) : 1131 - 1132
  • [48] Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tract
    Al-Karim, HA
    Tan, KE
    Chi, KN
    Bryce, CJ
    Murray, NR
    Coppin, C
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 515 - 519
  • [49] Phase II study of S-1 as a first-line, S-1 plus cisplatin as a second-line, and weekly paclitaxel as a third-line therapy in patients with advanced gastric carcinoma
    Yamada, T.
    Rino, Y.
    Kanari, M.
    Saeki, H.
    Yukawa, N.
    Wada, N.
    Ooshima, T.
    Yamada, R.
    Haruhiko, C.
    Masuda, M.
    Imada, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial
    Pectasides, D
    Glotsos, J
    Bountouroglou, N
    Kouloubinis, A
    Mitakidis, N
    Karvounis, N
    Ziras, N
    Athanassiou, A
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 243 - 250
12345